English | Español
Patient Daily | Dec 9, 2025

FDA extends review period for Ascendis Pharma's dwarfism drug TransCon CNP
Patient Daily | Dec 9, 2025

Regeneron partners with Tessera Therapeutics on gene editing therapy for AATD
Patient Daily | Dec 9, 2025

FDA’s advanced manufacturing designation may ease mid-development process changes for cell therapies
Patient Daily | Dec 9, 2025

Lilly reduces Zepbound prices amid ongoing competition with Novo Nordisk
Patient Daily | Dec 9, 2025

FDA official links child deaths to COVID-19 vaccines and proposes stricter review process
Patient Daily | Dec 9, 2025

Study finds rising rates of adolescent noise-induced hearing damage by age eighteen
Patient Daily | Dec 9, 2025

How data bias affects growth marketing strategies
Patient Daily | Dec 9, 2025

UK agrees to pay more for drugs in exchange for tariff exemption

Trending
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Insmed ends skin disease drug development after trial results fall short
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Novavax shareholder plans to oppose CEO pay and board at upcoming meeting
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

Kailera Therapeutics announces potential $533 million IPO in obesity drug market
+ Regulatory
Patient Daily | Apr 16, 2026

Health Analyst: Abuse of 340b drug discount program ‘leaves patients stuck in the middle’